INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 433m ago
HOUSE PTR33m ago
SEC 13F33m ago
ROBINHOOD CHAIN32m ago
HOUSE PTR/PurchaseVerified data

Julie Johnson bought FFIV

Joint · F5, INC. · F5, Inc. - Common Stock

Side
BUY
Value range
$1,001 – $15K
Shares
Not disclosed
Price
—
Executed
Oct 21, 2025
Disclosed
Aug 5, 2026
Disclosure timeline288 days from execution to publication · legal deadline 45 days
Oct 21 executedAug 5, 2026 disclosed

FFIV · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
39/ 100 · ELEVATED
Methodology →
  • Transaction type+14 / 20

    Purchase

  • Relative size+2 / 25

    Disclosed range starting at $1K

  • Filing timing+15 / 15

    Disclosed 288 days after execution (STOCK Act deadline: 45)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

  • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · FFIV

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    10
    MF
    Montoya Michael FChief Technology Ops Officer
    FFIVF5, INC.
    Option exercise
    M—
    1,603 sh
    Nov 1, 2026Nov 3, 2026
    traded Nov 1, 2026
    +2dSEC FORM 4

    Evidence

    6
    WC
    Werner Edward CooperChief Financial Officer
    FFIVF5, INC.
    Option exercise
    M—
    534 sh
    Nov 1, 2026Nov 3, 2026
    traded Nov 1, 2026
    +2dSEC FORM 4

    Evidence

    13
    OM
    Okeke Angelique MEVP, General Counsel
    FFIVF5, INC.
    Option exercise
    M—
    1,312 sh
    Nov 1, 2026Nov 3, 2026
    traded Nov 1, 2026
    +2dSEC FORM 4

    Evidence

    2
    MF
    Montoya Michael FChief Technology Ops Officer
    FFIVF5, INC.
    Grant or award
    A—
    3,928 sh
    Nov 2, 2026Nov 3, 2026
    traded Nov 2, 2026
    +1dSEC FORM 4

    Evidence

    9
    OM
    Okeke Angelique MEVP, General Counsel
    FFIVF5, INC.
    Option exercise
    M—
    250 sh
    Nov 1, 2026Nov 3, 2026
    traded Nov 1, 2026
    +2dSEC FORM 4

    Evidence

    5
    OM
    Okeke Angelique MEVP, General Counsel
    FFIVF5, INC.
    Option exercise
    M—
    114 sh
    Nov 1, 2026Nov 3, 2026
    traded Nov 1, 2026
    +2dSEC FORM 4

    Evidence

    5
    AK
    Anand KunalChief Technology Officer
    FFIVF5, INC.
    Grant or award
    A—
    7,855 sh
    Nov 2, 2026Nov 3, 2026
    traded Nov 2, 2026
    +1dSEC FORM 4

    Evidence

    19
    OM
    Okeke Angelique MEVP, General Counsel
    FFIVF5, INC.
    Tax withholding
    F$355K
    1,049 sh
    Nov 1, 2026Nov 3, 2026
    traded Nov 1, 2026
    +2dSEC FORM 4

    Evidence

    9
    AK
    Anand KunalChief Technology Officer
    FFIVF5, INC.
    Option exercise
    M—
    668 sh
    Nov 1, 2026Nov 3, 2026
    traded Nov 1, 2026
    +2dSEC FORM 4

    Evidence

    10
    WC
    Werner Edward CooperChief Financial Officer
    FFIVF5, INC.
    Option exercise
    M—
    453 sh
    Nov 1, 2026Nov 3, 2026
    traded Nov 1, 2026
    +2dSEC FORM 4

    Evidence

    2
    WC
    Werner Edward CooperChief Financial Officer
    FFIVF5, INC.
    Grant or award
    A—
    5,611 sh
    Nov 2, 2026Nov 3, 2026
    traded Nov 2, 2026
    +1dSEC FORM 4

    Evidence

    9
    PA
    Peterman Catherine AChief People Officer
    FFIVF5, INC.
    Option exercise
    M—
    1,077 sh
    Nov 1, 2026Nov 3, 2026
    traded Nov 1, 2026
    +2dSEC FORM 4

    Evidence

    24
    PA
    Peterman Catherine AChief People Officer
    FFIVF5, INC.
    Tax withholding
    F$144K
    426 sh
    Nov 1, 2026Nov 3, 2026
    traded Nov 1, 2026
    +2dSEC FORM 4

    Evidence

    13
    PA
    Peterman Catherine AChief People Officer
    FFIVF5, INC.
    Option exercise
    M—
    1,077 sh
    Nov 1, 2026Nov 3, 2026
    traded Nov 1, 2026
    +2dSEC FORM 4

    Evidence

    9
    PA
    Peterman Catherine AChief People Officer
    FFIVF5, INC.
    Grant or award
    A—
    3,367 sh
    Nov 2, 2026Nov 3, 2026
    traded Nov 2, 2026
    +1dSEC FORM 4

    Evidence

    9
    MA
    Maddison John AnthonyChief Product Mkting Officer
    FFIVF5, INC.
    Option exercise
    M—
    454 sh
    Nov 1, 2026Nov 3, 2026
    traded Nov 1, 2026
    +2dSEC FORM 4

    Evidence

    13
    OM
    Okeke Angelique MEVP, General Counsel
    FFIVF5, INC.
    Option exercise
    M—
    376 sh
    Nov 1, 2026Nov 3, 2026
    traded Nov 1, 2026
    +2dSEC FORM 4

    Evidence

    13
    AK
    Anand KunalChief Technology Officer
    FFIVF5, INC.
    Option exercise
    M—
    623 sh
    Nov 1, 2026Nov 3, 2026
    traded Nov 1, 2026
    +2dSEC FORM 4

    Evidence

    15
    AK
    Anand KunalChief Technology Officer
    FFIVF5, INC.
    Tax withholding
    F$872K
    2,577 sh
    Nov 1, 2026Nov 3, 2026
    traded Nov 1, 2026
    +2dSEC FORM 4

    Evidence

    9
    OM
    Okeke Angelique MEVP, General Counsel
    FFIVF5, INC.
    Option exercise
    M—
    238 sh
    Nov 1, 2026Nov 3, 2026
    traded Nov 1, 2026
    +2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    House Periodic Transaction Report
    Publisher
    Clerk of the U.S. House of Representatives
    Document ID
    20035035

    Timestamps

    Event (reported)
    Oct 21, 2025
    Published
    Aug 5, 2026
    Ingested by INSIDER
    Nov 5, 00:34 UTC
    Last re-read
    Nov 5, 06:47 UTC

    Extracted facts

    Filer
    Julie Johnson
    Role
    JointAs filed: “JT”
    Transaction
    PurchaseAs filed: “P”
    Asset
    F5, Inc. - Common Stock
    Ticker
    FFIV
    Reported value
    $1,001 – $15KAs filed: “$1,001 - $15,000”
    Execution date (reported)
    Oct 21, 2025
    Notification date (reported)
    Nov 6, 2025
    Days from execution to publication
    288

    Calculation

    Midpoint = (low + high) / 2. Used only to rank and sum ranges; the true value can be anywhere in the range.

    • Low: $1,001
    • High: $15,000

    = $8,001

    What this establishes

    Julie Johnson reported a purchase of F5, Inc. - Common Stock (owner: joint). Members report a value range, not an exact amount, and do not report share counts or prices. Dates are as entered by the filer. A trade report is not evidence of wrongdoing.

    Extraction

    Method
    PDF text extraction
    Confidence
    1.00
    Joint
    Julie Johnsonbioguide:J000310
    Issuer
    F5, INC.cik:0001048695

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.